Chemical Compound
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-Nonamethyl-33-[(2R,4E)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
CAS Registry Number
121584-18-7
Primary record
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-Nonamethyl-33-[(2R,4E)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 库存
- 7,243 克
- 纯度
- 99.6 %
- CAS
- 121584-18-7
化合物标识与属性
- CAS
- 121584-18-7
- PubChem CID
- 5281884
- SMILES
- C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
- Canonical SMILES
- C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
名称与同义词
- Valspodar
- Amdray
- Sdz psc 833
- Cyclosporin D
- Sdz-psc-833
- 121584-18-7
- Psc 833
- valspodarum
- PSC-833
- PSC833
- Amdray (TN)
- Cyclosporin A der.
- SDZ-PSC 833
- Valspodar (USAN/INN)
- Q7ZP55KF3X
- UNII-Q7ZP55KF3X
- VALSPODAR [INN]
- PSC833(Valspodar)/
- VALSPODAR [MI]
- Valspodar(PSC833)?
- Valspodar [USAN:INN]
- AC1NQZ8I
- VALSPODAR [USAN]
- RefChem:901608
- Tick anticoagulant peptide
- VALSPODAR [VANDF]
- 3'-Keto-bmt(1)-val(2)-cyclosporin A
- PSC-833(Valspodar)/
- Valspodar; (PSC-833
- Valspodar [USAN:INN:BAN]
- D09TGX
- D0I0ON
- D0V8LG
- VALSPODAR [MART.]
- DTXSID90873386
- VALSPODAR [WHO-DD]
- SDZ PSC833
- SCHEMBL17879
- MFCD00907207
- CHEBI:8985
- orb1706487
- C63H111N11O12
- CHEMBL1086218
- SCHEMBL21751941
- GTPL11745
- Tick anticoagulant peptide (TAP)
- YJDYDFNKCBANTM-QCWCSKBGSA-N
- DTXCID101508678
- EX-A2242
- ABP000726
- BDBM50390978
- AKOS024457945
- CID5281884
- CS-1074
- DB11869
- FV28665
- CID:5281884
- PSC 833;PSC-833;PSC833
- AN-32863
- AS-35155
- BC638767
- HY-17384
- SC-47431
- SID:53787223
- C63-H111-N11-O12
- A3905
- B5915
- Cyclosporin A, 6-[(2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoic acid]-7-L-valine-
- NS00116306
- X5944
- A11080
- C11213
- D06277
- 775C962
- A900229
- C070272
- SR-01000872585
- Q7120613
- SR-01000872585-1
- 6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic Acid]-7-L-valine-cyclosporin A
- BRD-K19412342-001-01-6
- BRD-K19412342-001-02-4
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 63775-96-2
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- Cyclosporin D, 6-((2S,4R,6E)-4-methyl-2-methylamino)-3-oxo-6-octenoic acid)-
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-((R,E)-2-methylhex-4-enoyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
- Cyclo(((2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoyl)-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl)
- decaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
- 6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic acid]ccyclosporin
- 6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic acid]cyclosporin D
- 6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoicacid]-7-L-valinecyclosporin A
- Cyclosporin D, 6-[(2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoic acid]-
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-Nonamethyl-33-[(2R,4E)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-((E,2R)-2-methylhex-4-enoyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-((R,E)-2-methylhex-4-enoyl)-1,4,7,10,13,16,19,22,25,28,31-un
- 6-[[R-(E)]-6,7-Didehydro-N,4-dimethyl-3-oxo-L -2-aminooctanoic acid]-7-L-valinecyclosporin A
- 99-66-1
- Cyclosporin A, 6-((R-(E))-6,7-didehydro-N,4-dimethyl-3-oxo-L-2-aminooctanoic acid)-7-L-valine-